首页> 美国卫生研究院文献>Cardiac Failure Review >Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
【2h】

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials

机译:主动脉瓣狭窄和心力衰竭:疾病的确定和临床试验的统计考虑。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event.
机译:主动脉瓣狭窄是一种进展性疾病,其发展历经数十年,一旦出现症状且未经治疗,会导致存活率下降。在过去的十年中,经导管主动脉瓣置换术已经有了长足发展,并将其适应症从手术无法操作的高危患者扩展到中度风险患者。心力衰竭相关结局的评估包括功能评估,针对特定疾病的生活质量调查以及对事件(例如住院)的标准化确定。目前正在测试多种统计方法,以说明复发事件,例如心力衰竭住院或合并二元和连续结果,两者均旨在评估疾病的整体负担,这与传统的首次发病时间分析相反。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号